Table 1.
Isolates | P. mirabilis | E. coli | S. aureus |
---|---|---|---|
rGO | |||
50 µg/ml | No zone | No zone | No zone |
100 µg/ml | No zone | No zone | No zone |
200 µg/ml | 18 ± 2 | 9 ± 1 | No zone |
nAg | |||
100 µg/ml | No zone | No zone | 8 ± 1 |
rGO–nAg | |||
100 µg/ml | 23 ± 2 | 25 ± 2 | 24 ± 1 |
Nitrofurantoin | |||
100 µg/ml | 24 ± 2 | No zone | 26 ± 1 |
As expected, the zone of inhibition for rGO and nAg was concentration-dependent. The concentrations of 50 µg/ml and 100 µg/ml of rGO and nAg, respectively, were insufficient to inhibit the organisms tested. At these concentrations, nitrofurantoin inhibited P. mirabilis and S. aureus, but not E. coli. rGO–nAg nanomaterial composite showed strong activity, inhibiting all pathogens tested, including E. coli shown to be resistant to standard antibiotic.